Neuromodulators, dermal fillers, biostimulators, and the longevity question. Label-first, comparison-shaped.
US Belotero duration is PMA- and area-specific. Healthline mixes EU SKUs. Intense P250016 is lips, not EU deep folds. Volume is 48-week cheeks versus Lyft, not Voluma's…
RHA duration is PMA- and area-specific. Manufacturer up-to-15-months is a 64-week NLF follow-up, not a median. Dynamic Volume midface is S048 18 Sep 2025, not the 13 Jan…
Radiesse duration is PMA- and area-specific. Manufacturer up-to-2-years is not the SSED table. Décolleté 1:2 is labeled; hyperdilute body is not.
How long Restylane lasts is product- and area-specific PMA data. Manufacturer up-to numbers are ceilings with touch-up, not medians. Contour is not Lyft.
Jeuveau's US label has Day 30 success, 20 Units, and retreatment at 3 months, not a 3-to-4-month duration sentence. 40 Units is unlabeled Phase 2.
How long Juvéderm lasts is product- and area-specific PMA data. Manufacturer up-to numbers are ceilings with touch-up, not medians. Volbella is not Vollure.
Only Botox Cosmetic and Xeomin are on-label for forehead lines, and both require treating the 11s at the same visit. Labeled units, Spock brow, and who should skip.
FDA approved RHA Redensity Eye on 12 May 2026 for infraorbital hollows. It is a 15 mg/g gel, the fourth on-label HA, not the first under-eye filler.
Xeomin and Botox Cosmetic share the 20/24/40/64-unit upper-face pattern. Xeomin has no platysma indication; units are not interchangeable on either label.
All six US aesthetic toxins are on-label for frown lines. Labeled doses, whether you can treat 11s alone, why etched lines can remain, and what 20 units costs.